Triple negative breast cancer is breast cancer that tests clinically negative in its expression of progesterone and estrogen receptors, and for HER2 proteins.
It is very aggressive, has distinct patterns of metastasis, has unique molecular profile, and doesn’t have targeted therapies that have been proven to work. Most triple negative breast cancers are “basal like” on [...]



